Latest PR here, from about a week ago: Premier Health Group Inc. Announces Plans to Enter Canadian Pharmacy & Drug Store Market
GlobeNewswire•November 5, 2018
VANCOUVER, British Columbia, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Premier Health Group (CSE: PHGI, OTCQB: PHGRF, Frankfurt: 6PH) (the “Company” or “Premier Health”), a Company focused on developing innovative approaches that combine human skill based expertise with emerging technologies for the healthcare industry, is pleased to announce that as a part of its expansion plans it will enter the Pharmacy market via acquisition and/or launching a new Canada based pharmacy in H1-2019.
“Pharmacy is a critical component in our commitment to providing patients with best in class primary care that is accessible and efficient in its delivery. Having the ability to prepare and deliver prescription and non-prescription pharmaceuticals and other health products to patients with ease, and having it as a part of our comprehensive technology solution for primary care, is something we are very excited to roll-out to patients,” said Dr. Essam Hamza, CEO of Premier.
The Company is actively reviewing a pipeline of additional pharmacy partners which include bricks and mortar locations for acquisition and strategic new retail opportunities for pharmacies. “It is our position that the emergence of technology such as the ability for patients to electronically send their prescription(s) to a pharmacy for fulfillment and pick up at a later time or delivery directly to them at home or work will result in increased patient and consumer enrollment in apps that offer this type of functionality,” added Dr.Hamza.
The Canadian retail pharmacy market is estimated to be $44 billion (Source:IBISWorld). It is expected the industry sector will continue to allow for favourable economics for pharmacy operators as baby boomer’s demand increases for prescriptions and operators expand scope of practice to include preventative services.
The Company expects to provide additional updates on acquisitions in Q4-18 and Q1-19.
ON BEHALF OF THE BOARD OF DIRECTORS
“Dr. Essam Hamza, MD"
Chief Executive Officer
AI
